Modified Lung Cancer Screening Eligibility Requirements May Reduce Racial Disparities in Lung Cancer Screening, Treatment

Debaters Argue Merits of Surgery in Malignant Meso in Light of MARS2 Data

Can pCR Be an Early Clinical Trial Endpoint? Initiative Aims to Answer That Question

Experts Debate Addition of Frontline Chemotherapy for EGFR+ NSCLC

Should Biomarkers Be Used in the Clinical Management of ES-SCLC?

In Case You Missed It: IASLC Launches New Education Center

IASLC Launches Global Member Survey on Diversity, Equity, and Inclusion

FLAURA 2 Post-progression Outcomes Demonstrate Consistent Benefit, Favor Combination Arm

MARIPOSA-2 Post-progression Analysis Favors Amivantamab-Chemotherapy Combination

Can Artificial Intelligence Identify Those at High Risk and Shift the Lung Cancer Screening Paradigm?

In Case You Missed It: Recent News from IASLC

WCLC Attendees Hear Preview of Proposed Changes for the 9th Edition of the TNM Staging Classification for Thoracic Cancers